Delayed OTC Markets 5-day change 1st Jan Change
- USD -.--% Intraday chart for ReGen Biologics Inc. -.--% -

Valuation: ReGen Biologics Inc.

Market Cap 1.17M 1.03M 950K 877K 1.66M 112M 1.69M 11.32M 4.44M 54.81M 4.41M 4.31M 190M P/E 2007
-0.9x
P/E 2008 -1.66x
Enterprise Value 11.46M 10.06M 9.28M 8.57M 16.23M 1.09B 16.52M 111M 43.37M 535M 43.02M 42.08M 1.86B EV / Sales 2007
14x
EV / Sales 2008 22.7x
Free-Float
100%
Yield 2007 *
-
Yield 2008 -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 25
-0.50%-1.54%-28.85%-12.62% 164B
+1.80%+0.82%-6.73%-3.92% 107B
+0.32%+2.34%+2.79%+57.04% 59.04B
+0.79%-3.68%+39.99%+54.50% 51.72B
+0.72%-3.88%-13.66%-41.41% 41.87B
+0.47%-4.98% - - 34.7B
+2.66%+5.21%-10.09%-42.88% 28.93B
-1.10%-3.29%+55.70%-5.76% 24.99B
0.00%-1.01%-5.28%-3.57% 21.05B
Average +0.52%-0.93%+4.23%+0.17% 53.33B
Weighted average by Cap. +0.50%-0.93%-5.60%+1.02%

Financials

2007 2008
Net sales 986K 865K 799K 737K 1.4M 94.03M 1.42M 9.51M 3.73M 46.06M 3.7M 3.62M 160M 1.37M 1.21M 1.11M 1.03M 1.95M 131M 1.98M 13.26M 5.2M 64.18M 5.16M 5.05M 223M
Net income -10.38M -9.11M -8.4M -7.76M -14.7M -990M -14.96M -100M -39.28M -485M -38.96M -38.11M -1.68B -9.95M -8.73M -8.06M -7.44M -14.09M -949M -14.35M -96.03M -37.67M -465M -37.36M -36.55M -1.61B
Net Debt 4.09M 3.59M 3.31M 3.06M 5.8M 390M 5.9M 39.5M 15.49M 191M 15.37M 15.03M 663M 10.28M 9.03M 8.33M 7.69M 14.57M 981M 14.83M 99.25M 38.93M 480M 38.61M 37.77M 1.67B
Logo ReGen Biologics Inc.
Regen Biologics Inc (ReGen) is a United States-based development stage orthopedic products company. The Company develops, manufactures and markets tissue growth and repair products for United States and global markets. The Company's collagen matrix technology includes applications in orthopedics, general surgery, spine, cardiovascular and drug delivery. Some of these applications are marketable while others are in various stages of development. Its approved product using its collagen matrix technology is the Menaflex collagen meniscus implant device (also known as the CMI), which is marketed for sale in the European Union (EU), Switzerland, Turkey, and the Republic of South Africa, through the Company’s subsidiary, ReGen Biologics AG.
Employees
-
  1. Stock Market
  2. Stocks
  3. RGBOQ Stock